Literature DB >> 21783550

In vitro and other alternative approaches to developmental neurotoxicity testing (DNT).

Pamela Lein1, Ellen Silbergeld, Paul Locke, Alan M Goldberg.   

Abstract

To address the growing need for scientifically valid and humane alternatives to developmental neurotoxicity testing (DNT), we propose that basic research scientists in developmental neurobiology be brought together with mechanistic toxicologists and policy analysts to develop the science and policy for DNT alternatives that are based on evolutionarily conserved mechanisms of neurodevelopment. In this article we briefly review in vitro and other alternative models and present our rationale for proposing that resources be focused on adapting alternative simple organism systems for DNT. We recognize that alternatives to DNT will not completely replace a DNT paradigm that involves in vivo testing in mammals. However, we believe that alternatives will be of great value in prioritizing chemicals and in identifying mechanisms of developmental neurotoxicity, which in turn will be useful in refining and reducing in vivo mammalian tests for exposures most likely to be hazardous to the developing human nervous system.

Entities:  

Year:  2005        PMID: 21783550     DOI: 10.1016/j.etap.2004.12.035

Source DB:  PubMed          Journal:  Environ Toxicol Pharmacol        ISSN: 1382-6689            Impact factor:   4.860


  32 in total

Review 1.  Translating neurobehavioural endpoints of developmental neurotoxicity tests into in vitro assays and readouts.

Authors:  Christoph van Thriel; Remco H S Westerink; Christian Beste; Ambuja S Bale; Pamela J Lein; Marcel Leist
Journal:  Neurotoxicology       Date:  2011-10-12       Impact factor: 4.294

2.  Differentiating neurons derived from human umbilical cord blood stem cells work as a test system for developmental neurotoxicity.

Authors:  Mahendra P Kashyap; Vivek Kumar; Abhishek K Singh; Vinay K Tripathi; Sadaf Jahan; Ankita Pandey; Ritesh K Srivastava; Vinay K Khanna; Aditya B Pant
Journal:  Mol Neurobiol       Date:  2014-05-24       Impact factor: 5.590

Review 3.  Opportunities and challenges for using the zebrafish to study neuronal connectivity as an endpoint of developmental neurotoxicity.

Authors:  Galen W Miller; Vidya Chandrasekaran; Bianca Yaghoobi; Pamela J Lein
Journal:  Neurotoxicology       Date:  2018-04-25       Impact factor: 4.294

4.  Developmental and behavioral alterations in zebrafish embryonically exposed to valproic acid (VPA): An aquatic model for autism.

Authors:  Jiangfei Chen; Lei Lei; Linjie Tian; Fei Hou; Courtney Roper; Xiaoqing Ge; Yuxin Zhao; Yuanhong Chen; Qiaoxiang Dong; Robert L Tanguay; Changjiang Huang
Journal:  Neurotoxicol Teratol       Date:  2018-01-05       Impact factor: 3.763

5.  Single-neuron axonal pathfinding under geometric guidance: low-dose-methylmercury developmental neurotoxicity test.

Authors:  Lina Wei; Andrew J Sweeney; Liyuan Sheng; Yu Fang; Mark S Kindy; Tingfei Xi; Bruce Z Gao
Journal:  Lab Chip       Date:  2014-07-21       Impact factor: 6.799

6.  Changes in thyroid hormone activity disrupt photomotor behavior of larval zebrafish.

Authors:  Kyla M Walter; Galen W Miller; Xiaopeng Chen; Danielle J Harvey; Birgit Puschner; Pamela J Lein
Journal:  Neurotoxicology       Date:  2019-05-20       Impact factor: 4.294

7.  Chlorpyrifos-oxon disrupts zebrafish axonal growth and motor behavior.

Authors:  Dongren Yang; Holly Lauridsen; Kalmia Buels; Lai-Har Chi; Jane La Du; Donald A Bruun; James R Olson; Robert L Tanguay; Pamela J Lein
Journal:  Toxicol Sci       Date:  2011-02-23       Impact factor: 4.849

8.  Potential frameworks to support evaluation of mechanistic data for developmental neurotoxicity outcomes: A symposium report.

Authors:  Laura M Carlson; Frances A Champagne; Deborah A Cory-Slechta; Laura Dishaw; Elaine Faustman; William Mundy; Deborah Segal; Christina Sobin; Carol Starkey; Michele Taylor; Susan L Makris; Andrew Kraft
Journal:  Neurotoxicol Teratol       Date:  2020-02-14       Impact factor: 3.763

9.  Chlorpyrifos and chlorpyrifos-oxon inhibit axonal growth by interfering with the morphogenic activity of acetylcholinesterase.

Authors:  Dongren Yang; Angela Howard; Donald Bruun; Mispa Ajua-Alemanj; Cecile Pickart; Pamela J Lein
Journal:  Toxicol Appl Pharmacol       Date:  2007-11-17       Impact factor: 4.219

Review 10.  Biological and medical applications of a brain-on-a-chip.

Authors:  David Pamies; Thomas Hartung; Helena T Hogberg
Journal:  Exp Biol Med (Maywood)       Date:  2014-06-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.